Related content

Skin and Nail Responses after 1 Year of Infliximab Therapy in Patients with Moderate-to-Severe Psoriasis: A Retrospective Analysis of the EXPRESS Trial

By  

Dermatology, Vol. 221, Iss. 2, 2010-07 ,pp. : 172-178

Karger

Access to resources Recommend Favorite

Ustekinumab Induces Fast Response and Maintenance of Very Severe Refractory Scalp Psoriasis: Results in Two Greek Patients from the Psoriasis Hospital-Based Clinic

By  

Dermatology, Vol. 228, Iss. 2, 2014-02 ,pp. : 107-111

Karger

Access to resources Recommend Favorite

Striking and Rapid Improvement of Plaque Psoriasis with Infliximab

By  

Dermatology, Vol. 207, Iss. 1, 2003-07 ,pp. : 54-56

Karger

Access to resources Recommend Favorite

Relationship between Clinical Response to Therapy and Health-Related Quality of Life Outcomes in Patients with Moderate to Severe Plaque Psoriasis

By  

Dermatology, Vol. 216, Iss. 3, 2008-01 ,pp. : 260-270

Karger

Access to resources Recommend Favorite

Recommendations for the Long-Term Treatment of Psoriasis with Infliximab: A Dermatology Expert Group Consensus

By  

Dermatology, Vol. 217, Iss. 3, 2008-08 ,pp. : 268-275

Karger

Access to resources Recommend Favorite